The Warsaw Stock Exchange-listed medtech company has signed a distribution agreement for PocketECG with Health Test Australia, a well-established partner in the Australian market. The comprehensive diagnostic technology, developed and introduced globally by Medicalgorithmics, enables physicians to remotely monitor heart rhythm variability in patients in a convenient and patient-friendly manner. The agreement strengthens the presence of the sWIG80-listed medtech company in the APAC market, where, in addition to Australia, Medicalgorithmics’ innovative solutions are also distributed in India, Indonesia, and the Philippines.
“Expanding our presence in promising markets is a key part of our global expansion strategy, through which our innovative products are already available in 23 markets. The agreement with Health Test Australia ensures that both our AI-based software and PocketECG will be distributed in the APAC region. We consistently execute our growth strategy by systematically acquiring partners in new markets while strengthening our presence in existing ones, which, given the advantages of our innovative solutions, we identify as having significant growth potential,” commented Jarosław Jerzakowski, Member of the Management Board of Medicalgorithmics for Operations and Sales.
PocketECG is a leading personal ECG monitor that offers users the most advanced full-scale monitoring and comprehensive analysis for physicians, enabling them to remotely oversee heart rhythm variability in patients. This pocket-sized ECG device allows physicians to expand their practice and effectively diagnose heart diseases in daily clinical settings. The small and convenient portable cardiac monitor provides precise reporting with a wide range of statistics available to doctors, including data on all known types of arrhythmias, serving as the basis for treatment selection. It also helps detect correlations between physical activity and arrhythmias. PocketECG can seamlessly switch between Holter tests, event monitoring, and multi-week mobile cardiac telemetry without requiring a patient visit to the doctor’s office.